In the latest LDS news, a demographer predicts the church's missionary force will start to shrink, and apostle David Bednar ...

There are many stories associated with Sinai, from the tales of St. Catherine to those of Prophet Moses, as well as numerous ...

The new ‘GLed’ tool, unique in its reversibility, allows the functional state of T cells to be observed for the first time, ...

Researchers at the University of Granada and Mount Sinai Hospital in New York have developed a luminescent probe, called GLed ...

People want to live here. People want to thrive here. We want to be a catalyst in doing that to help people rebuild what was once a proud city.” ...

A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

Sharing isn't always caring. Doctors reveal the personal care items that can harbor disease-causing germs and why you should ...

Recent research has highlighted the effects of disorders of gut-brain interaction and environmental stressors — including ...

The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic ...

Kumar, MD, a board-certified radiation oncologist who recently joined the staff at the WVU Cancer Institute at Wheeling ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company ...

Uterine cancer represents a significant and growing global health challenge, experts said as they called upon governments and multilateral institutions to explicitly integrate it into global and ...